Renaissance Capital logo

IPO Center

Research IPOs and Discover New Stocks

IPOs IN THE NEWS

OPAY

US IPO Week Ahead: Africa-focused fintech target’s week sole IPO as Anthropic nears its public filing

One IPO is currently scheduled for the week ahead as investors continue to hold their breath for the year’s last potential mega IPO. Africa-focused digital bank and fintech platform OPay (OPAY) plans to raise $320 million at a $4.2 billion market cap....read more

RZRA

US IPO Weekly Recap: Trickle of biotech activity continues amid tech sell-off

One biotech IPO debuted this week, while four IPOs submitted initial filings, including two sizable biotech filings. Allergy and autoimmune biotech Lycia Therapeutics (LYCA) priced its upsized IPO at the top of the range to raise $318 million at a $1.1...read more

BHAIU

SPAC: BHAV Acquisition II lowers deal size by 33% ahead of $100 million IPO

BHAV Acquisition II, a blank check company targeting robotics, EVs, fintech, advanced computing and energy tech, lowered the proposed deal size for its upcoming IPO on Friday. The Piscataway, NJ-based company now plans to raise $100 million by offering 10...read more

READ ALL IPO NEWS

IPO ETF

IPO International ETF

U.S. IPO Performance

Upcoming 2026 IPOs
Company Ticker
Trade
Date
Shares (M) Price Range Deal Size ($M) Underwriters
OPay OPAY Get date on IPO Pro 16.0 $19.00 - $21.00 $320 Citi
Deutsche Bank

IPO PRO TIP

Create custom screens and filters to see when IPOs are coming up. Explore full IPO Calendar

Recently Priced IPOs
Company Ticker Offer Date Deal Size ($M) Current Price Today's Change Return from IPO
Lycia Therapeutics LYCA 10/22/26 $318 $30.00
$0.00
(0.0%)
66.7%
City Therapeutics CTY 10/15/26 $200 $20.77
$0.00
(0.0%)
15.4%
Amaero AMRO 10/14/26 $20 $5.84
$0.00
(0.0%)
37.4%

IPO PRO TIP

The IPO price is the price the underwriters will sell stock to institutional and accredited investors. Learn more at IPO University

Q3 2026 US Market Review

2026 Q3 US Review cover
Download Now

Get the Preview

Pricing Activity

IPO Proceeds Raised

IPO ETF

NEW STOCKS ONLY
(Avg. Age 1.3 Years)

0.1%
overlap*

S&P 500

OLDER STOCKS
(Avg. Age 43 Years)

*By Weight, as of 01/01/2026

Seek to Diversify Your Portfolio

The IPO ETF has almost NO Overlap with the S&P 500

The IPO ETF only contains New Stocks

How to Invest

New to IPOs?

We Wrote The Book

Explore IPO University

View IPO Glossary by Letter


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z